AngioDynamics, Inc. (ANGO) Operating income 2017–2026
AngioDynamics, Inc. (ANGO) annual operating income history from SEC filings — each fiscal year as reported.
-$39.9MFY2026 · since FY2017: -$11.2M → -$39.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$39.9M | +0.1% |
| FY2025 | -$40.0M | +79.2% |
| FY2024 | -$192.4M | -276.0% |
| FY2023 | -$51.2M | -79.8% |
| FY2022 | -$28.5M | +19.3% |
| FY2021 | -$35.3M | +78.9% |
| FY2020 | -$167.1M | -1678.4% |
| FY2019 | -$9.4M | +33.7% |
| FY2018 | -$14.2M | -26.8% |
| FY2017 | -$11.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ANGO financial trends
ANGO RevenueANGO Net incomeANGO Net marginANGO Gross profitANGO Gross marginANGO Operating marginANGO Operating cash flowANGO Free cash flowANGO Capital expendituresANGO Return on equityANGO Stock buybacksANGO Dividends paidANGO Total assetsANGO Total liabilitiesANGO Shareholders’ equityANGO overview →